Davis Cancer Pavilion and Shands Medical Plaza

Gainesville, Florida 32608

0 studies enrolling now · 2 studies all time

What they study most

GIST, Lymphoma, Non-Hodgkin

Studies at this site

• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib — Completed